Deutsche Bank’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-105,177
| Closed | -$32.6K | – | 3664 |
|
|
2025
Q1 | $32.6K | Hold |
105,177
| – | – | ﹤0.01% | 3406 |
|
|
2024
Q4 | $97.8K | Hold |
105,177
| – | – | ﹤0.01% | 3247 |
|
|
2024
Q3 | $124K | Hold |
105,177
| – | – | ﹤0.01% | 3101 |
|
|
2024
Q2 | $81K | Buy |
105,177
+81,196
| +339% | +$62.5K | ﹤0.01% | 3143 |
|
|
2024
Q1 | $73.1K | Buy |
23,981
+1,097
| +5% | +$3.35K | ﹤0.01% | 3241 |
|
|
2023
Q4 | $73.7K | Sell |
22,884
-1,136
| -5% | -$3.66K | ﹤0.01% | 3299 |
|
|
2023
Q3 | $92.2K | Buy |
+24,020
| New | +$92.2K | ﹤0.01% | 3169 |
|
|
2021
Q3 | – | Sell |
-85,566
| Closed | -$335K | – | 4399 |
|
|
2021
Q2 | $335K | Buy |
85,566
+53,514
| +167% | +$210K | ﹤0.01% | 3452 |
|
|
2021
Q1 | $128K | Sell |
32,052
-440
| -1% | -$1.76K | ﹤0.01% | 3797 |
|
|
2020
Q4 | $75K | Buy |
32,492
+6,074
| +23% | +$14K | ﹤0.01% | 3912 |
|
|
2020
Q3 | $152K | Buy |
26,418
+4,633
| +21% | +$26.7K | ﹤0.01% | 3314 |
|
|
2020
Q2 | $160K | Buy |
+21,785
| New | +$160K | ﹤0.01% | 3194 |
|
|
2020
Q1 | – | Sell |
-23,165
| Closed | -$96K | – | 4391 |
|
|
2019
Q4 | $96K | Buy |
23,165
+12,896
| +126% | +$53.4K | ﹤0.01% | 3527 |
|
|
2019
Q3 | $33K | Buy |
10,269
+6,938
| +208% | +$22.3K | ﹤0.01% | 3979 |
|
|
2019
Q2 | $6K | Sell |
3,331
-253,931
| -99% | -$457K | ﹤0.01% | 4654 |
|
|
2019
Q1 | $454K | Buy |
257,262
+205,230
| +394% | +$362K | ﹤0.01% | 3460 |
|
|
2018
Q4 | $125K | Sell |
52,032
-196,420
| -79% | -$472K | ﹤0.01% | 3984 |
|
|
2018
Q3 | $1.41M | Sell |
248,452
-56,771
| -19% | -$322K | ﹤0.01% | 3059 |
|
|
2018
Q2 | $2.38M | Buy |
305,223
+9,501
| +3% | +$74.1K | ﹤0.01% | 2823 |
|
|
2018
Q1 | $2.09M | Buy |
295,722
+84,621
| +40% | +$598K | ﹤0.01% | 2811 |
|
|
2017
Q4 | $2.08M | Buy |
211,101
+6,607
| +3% | +$65.2K | ﹤0.01% | 2667 |
|
|
2017
Q3 | $1.75M | Sell |
204,494
-1,332
| -0.6% | -$11.4K | ﹤0.01% | 2605 |
|
|
2017
Q2 | $2.16M | Buy |
+205,826
| New | +$2.16M | ﹤0.01% | 2486 |
|